We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

WATERS CORPORATION

Waters Corp. designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performan... read more Featured Products: More products

Download Mobile App




Protein Saliva Test Diagnoses Autism

By LabMedica International staff writers
Posted on 11 Feb 2015
Autism spectrum disorder (ASD) currently affects one in 68 US children, and the number of people diagnosed with autism continues to rise, and diagnosis is currently made based on behavioral observations, but no biological test for autism exists.

Recent developments in biochemistry technology could help facilitate study of ASD at the protein level, providing much-needed insights into causes and consequences and convergence of multiple genetic pathways to affect a few common protein biomarkers has been proposed. More...


Scientists at Clarkson University (Potsdam, NY, USA) collected human saliva samples at a neuropsychology clinic and participant identities were unknown to the investigators conducting the study. Participants, ages 5 to 17, either had ASD diagnosed or were control subjects without any ASD diagnosis or diagnosis of any other neurodevelopmental, psychiatric, or major medical condition. Saliva samples from six donors were analyzed twofold. In the first case, six individual saliva samples from six donors were pooled in one ASD sample (ASD pooled sample) and the same was done with the six control samples.

The samples were analyzed by a nanoliquid chromatography-tandem mass spectrometer (nanoLC-MS/MS) using a NanoAcquity UPLC (Waters Corp.; Milford, MA, USA) coupled to a Waters’ quadrupole-time-of-flight (QTOF) Micro MS through a 20 µm ID picotip emitter (New Objective, Woburn, MA, USA). Quantitation of differentially regulated proteins within each individual ASD and control samples was performed in two ways: precursor ion intensity and spectral counting.

The team found statistically significant differences in several salivary proteins, including elevated prolactin-inducible protein, lactotransferrin, immunoglobulin (Ig) kappa chain C region, Ig gamma-1 chain C region, Ig lambda-2 chain C regions, neutrophil elastase, polymeric immunoglobulin receptor and deleted in malignant brain tumors 1. The proteins identified primarily have functions in immune system responses, or are elevated in people with gastrointestinal problems. The group also reported that several of the identified proteins interact with one another.

Costel C. Darie, PhD, a co-lead author and proteomics expert said, “We are the first in the world who proposed a protein complex as a potential biomarker signature, which gives us information not only about the proteins, their relative quantities and their modifications, but also about their interactions with other proteins.” The work is promising for the eventual development of an autism diagnostic test although more subjects need to be studied to confirm that the markers are consistently different in people with autism. The study was published on January 27, 2015, in the journal Autism Research.

Related Links:

Clarkson University
Waters Corp.
New Objective



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.